Country Club Bank GFN Sells 46,715 Shares of Corteva, Inc. (NYSE:CTVA)

Country Club Bank GFN reduced its position in Corteva, Inc. (NYSE:CTVAFree Report) by 40.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 70,217 shares of the company’s stock after selling 46,715 shares during the period. Country Club Bank GFN’s holdings in Corteva were worth $3,377,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Corteva by 2.4% in the 3rd quarter. Vanguard Group Inc. now owns 81,346,924 shares of the company’s stock valued at $4,161,709,000 after purchasing an additional 1,941,323 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Corteva by 1.4% in the 1st quarter. Geode Capital Management LLC now owns 14,726,824 shares of the company’s stock valued at $886,490,000 after purchasing an additional 208,948 shares during the last quarter. Northern Trust Corp raised its position in shares of Corteva by 2.7% in the 3rd quarter. Northern Trust Corp now owns 12,505,783 shares of the company’s stock valued at $639,796,000 after purchasing an additional 327,321 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Corteva by 29.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 11,095,076 shares of the company’s stock valued at $567,624,000 after purchasing an additional 2,545,570 shares during the last quarter. Finally, Morgan Stanley raised its position in shares of Corteva by 8.6% in the 4th quarter. Morgan Stanley now owns 9,452,940 shares of the company’s stock valued at $555,644,000 after purchasing an additional 746,972 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Price Performance

CTVA traded down $0.18 on Tuesday, hitting $57.50. 509,673 shares of the company’s stock were exchanged, compared to its average volume of 3,787,702. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $63.37. The company has a current ratio of 1.56, a quick ratio of 0.90 and a debt-to-equity ratio of 0.09. The firm has a 50-day moving average price of $53.45 and a 200-day moving average price of $49.86. The stock has a market cap of $40.19 billion, a price-to-earnings ratio of 56.55, a P/E/G ratio of 1.48 and a beta of 0.77.

Corteva (NYSE:CTVAGet Free Report) last announced its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.09. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The company had revenue of $3.71 billion for the quarter, compared to analysts’ expectations of $3.54 billion. During the same quarter in the previous year, the company posted $0.16 EPS. As a group, equities analysts anticipate that Corteva, Inc. will post 2.87 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.64 annualized dividend and a yield of 1.11%. Corteva’s dividend payout ratio (DPR) is presently 62.75%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Wolfe Research assumed coverage on shares of Corteva in a research report on Friday, March 1st. They set an “outperform” rating and a $67.00 price target for the company. Wells Fargo & Company raised their price target on shares of Corteva from $54.00 to $65.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Barclays raised their price target on shares of Corteva from $50.00 to $55.00 and gave the stock an “equal weight” rating in a research report on Friday, February 2nd. Loop Capital raised shares of Corteva from a “hold” rating to a “buy” rating and raised their price target for the stock from $57.00 to $65.00 in a research report on Monday, February 12th. Finally, Oppenheimer raised their price objective on shares of Corteva from $60.00 to $62.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $63.14.

View Our Latest Report on Corteva

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Read More

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.